Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

van Schouwenburg PA, Rispens T, Wolbink GJ. Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol. 2013;9:164-72. Abstract Currently, five anti-TNF biologic agents…

Find Out More

In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes) a promising new tool for tolerance induction and treatment of autoimmunity

Cousens LP, et al Scott DW, De Groot AS. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for…

Find Out More

Biosimilars: what clinicians should know

Weise M et al. Blood. 2012;120:5111-7. Abstract Biosimilar medicinal products (biosimilars) have become a reality in the European Union and will soon be available in the…

Find Out More

Setting the stage for biosimilar monoclonal antibodies

Schneider CK et al. Setting the stage for biosimilar monoclonal antibodies. Nature Biotech. 2012;30:1179-85. Abstract With the first marketing authorization application for a biosimilar monoclonal…

Find Out More

6th GCC Focus on LBA: Critical Reagents, Positive Controls and Reference Standards; Specificity for Endogenous Compounds; Biomarkers; Biosimilars

Abstract The 6th Global CRO Council for Bioanalysis (GCC) Closed Forum was held on 27 March 2012 in San Antonio, TX, USA, the day before…

Find Out More

Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars

Abstract The 6th Global CRO Council for Bioanalysis (GCC) Closed Forum was held on 27 March 2012 in San Antonio, TX, USA, the day before…

Find Out More

Recommendations on biomarker bioanalytical method validation by GCC

Abstract The 5th GCC in Barcelona (Spain) and 6th GCC in San Antonio (TX, USA) events provided a unique opportunity for CRO leaders to openly…

Find Out More

Challenges of developing and validating immunogenicity assays to support comparability studies for biosimilar drug development

Abstract Imminent patent expiry for a number of biological products currently on the market (many of which are blockbusters) has created an increasing opportunity for…

Find Out More

Recommendations on the Interpretation of the New European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)

Abstract Senior representatives of GCC member companies have thoroughly evaluated and discussed the new European Medicines Agency (EMA; July 2011) Guideline on Bioanalytical Method Validation…

Find Out More

Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process

Published by The AAPS Journal Conclusion For end users, effective laboratory data management is critical to an efficient LBA laboratory in the twenty-first century. An…

Find Out More